Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AltiBio, Inc. (AltiBio) was founded in early 2017 by a team with successful experience developing and commercializing orphan therapeutics. AltiBio currently has three projects in development: ATB223, ATB224, and ATB338, with two molecules, for one rare disease.

List your booth number for exhibitions, ask us